This metabolite provides a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 approximately 50% on the mother or father drug. Plasma concentrations of the metabolite are close to forty% of those observed for sildenafil, so that the metabolite accounts for about twenty% of sildenafil’s pharmacologic consequences.N… Read More